ÂÜÀòÂÒÂ×

Mr. William (Bill) Brinkerhoff, MS, MBA, served as the President of AlphaCore Pharma LLC until his retirement in 2013. Bill co-founded Cerenis Therapeutics in 2005 and served as its Chief Operating Officer until 2011. He was Vice President of Business Development for Esperion Therapeutics Inc. where he successfully negotiated multiple large potential partnering agreements prior to Esperion's acquisition by Pfizer. Before joining Esperion, Bill was Director of Business Development at Sankyo Co., a Tokyo-based pharmaceutical company. While at Sankyo, he was a member of the Senior Negotiating Team that formed the Sankyo/ Parke-Davis joint venture. Bill has over 20 years of commercial and management experience in the pharmaceutical industry and serves on the board of ONL Therapeutics. He received B.S. and M.S. degrees in Industrial and Operations Engineering and an M.B.A. from the University of Michigan.